An independent review of Strut Health's BBB rating, consumer complaints, regulatory standing, and what the complaint patterns mean for patients considering compounded hair, skin, or sexual-health treatments.
An independent look at Strut Health's LegitScript status, state licensing, BBB record, FDA compliance, and complaint history so you can make an informed decision before ordering.
A critical, evidence-based look at Strut Health, who should not use this cash telehealth platform for ED, hair loss, or peptides, plus what the data say about safety and legitimacy.
An independent review of Talkiatry's BBB rating, complaint patterns, state licensing records, and consumer feedback to help patients decide if the platform is right for them.
Not every patient is a good fit for Talkspace. This clinically reviewed guide identifies the specific mental health conditions, risk levels, and care needs that make Talkspace a poor or unsafe choice, with evidence-based alternatives.
An independent review of Thirty Madison BBB ratings, FTC complaints, state regulatory filings, and consumer-reported issues across Keeps, Cove, Facet, and Picnic. Includes original complaint-category analysis and clinical context.
An evidence-based, independent review of Thirty Madison's medical leadership, clinical credentials, licensing model, and safety record across Keeps, Cove, Facet, and Sadie.
An independent, evidence-based review of Thirty Madison's prescribing practices, outcomes data, complaints record, and regulatory standing across its Keeps, Cove, and Facet brands.
An independent review of Thorne's LegitScript status, NSF and USP certifications, FDA warning history, BBB rating, and consumer complaints.
An evidence-based, critical review of Thorne's medical leadership, scientific advisory structure, manufacturing credentials, third-party certifications, and complaint history. prepared by the HealthRX.com Editorial Team.
An independent, evidence-based review of Thorne's supplement quality, third-party testing, prescribing patterns among clinicians, and outcomes data. Learn what the research and regulatory records actually say.
A critical, evidence-based review of Thorne supplements covering who should avoid specific Thorne products, common complaints, regulatory standing, and how to evaluate quality claims before purchasing.
An independent review of Thrive Cause complaints filed with the BBB, state pharmacy boards, and the FDA. Covers legitimacy signals, compounding regulations, and what consumers should check before ordering compounded peptides.
An independent review of Transcend's BBB rating, consumer complaints, FDA enforcement history, and LegitScript status for hormone optimization and peptide therapy. prepared by the HealthRX.com Editorial Team.
An independent, evidence-based look at Transcend's medical leadership, physician credentials, regulatory standing, and how the telehealth brand compares against FDA and state medical board standards for hormone therapy and peptide prescribing.
An independent review of TrimRx's LegitScript certification status, state pharmacy board standing, FDA compounding compliance, and BBB record, with primary-source citations throughout.
A critical, evidence-based review of TrimRx compounded semaglutide and tirzepatide. Learn which patients should avoid TrimRx, what the FDA and BBB say, and how to evaluate whether this cash-pay compounding service is appropriate for you.
An independent, evidence-based review of Truepill's LegitScript accreditation status, state pharmacy board standing, FDA compliance history, BBB complaints, and what those records mean for patients using Truepill-powered telehealth platforms.
An independent, evidence-based review of WeightWatchers' medical leadership, clinical credentials, telehealth model, GLP-1 prescribing practices, and complaint history. prepared by the HealthRX.com Editorial Team.
An independent review of Willow telehealth's GLP-1 prescribing patterns, available outcomes data, regulatory standing, and what patients should verify before starting treatment.
A critical, evidence-grounded look at Willow's GLP-1 and women's health pricing history, plan changes, complaint patterns, and how to evaluate whether the service is legitimate before you spend.
A critical, evidence-based look at which patients should avoid Willow's GLP-1 telehealth platform, plus an honest review of its legitimacy, complaints, and clinical safety considerations.
An independent review of Winona telehealth's BBB rating, consumer complaint patterns, FDA compounding rules, and state pharmacy oversight, with primary-source citations throughout.
An independent review of Winona's LegitScript status, state pharmacy licensing, BBB complaints, FDA compliance, and prescribing standards for menopause HRT telehealth.
An independent, evidence-based review of Winona menopause telehealth identifying patient profiles for whom Winona is contraindicated, risky, or simply a poor clinical fit, with cited primary sources.
An independent review of Wisp telehealth's LegitScript certification status, BBB rating, state pharmacy board compliance, and patient complaint patterns. prepared by the HealthRX.com Editorial Team.
An independent, evidence-based review of Women's International Pharmacy BBB ratings, consumer complaints, FDA oversight, state board actions, and LegitScript status for compounded BHRT.
An independent, evidence-based review of Women's International Pharmacy: compounding legitimacy, FDA and state board oversight, complaint patterns, BHRT outcomes data, and what prescribers and patients should know before filling.
An independent review of ZOE's LegitScript status, BBB rating, FDA regulatory standing, and accreditation record. Find out what the evidence says before you subscribe.
An independent, evidence-based review of ZOE's personalized nutrition platform, its CGM-based methodology, published outcome data, regulatory standing, and common complaints, with primary-source citations throughout.
An independent, evidence-based review of Willow's GLP-1 telehealth platform for women, what patients actually experience, how outcomes compare to clinical trial benchmarks, and how Willow stacks up against alternatives.
A comparison of Winona and its top alternatives for menopause HRT, including cost, prescribing scope, and evidence behind each platform.
An evidence-based synthesis of Winona telehealth HRT outcomes, costs, prescription options, and how it compares to alternatives. prepared by the HealthRX.com Editorial Team.
An independent clinical review of Women's International Pharmacy, its compounded BHRT model, costs, legitimacy, and how it compares to alternatives, prepared by the HealthRX.com Editorial Team.
An evidence-based synthesis of Women's International Pharmacy compounded BHRT outcomes, safety data, regulatory standing, and how it compares to FDA-approved hormone therapies. prepared by the HealthRX.com Editorial Team.
An evidence-based patient profile for Women's International Pharmacy, covering compounded BHRT candidacy, safety data, cost, and how it compares to FDA-approved alternatives.
An evidence-based review of ZOE's personalized nutrition and CGM program, examining its clinical trial data, what independent research supports, where the gaps remain, and how it compares to medical alternatives.
A clinician-level review of bremelanotide (Vyleesi) microdosing protocols, standard FDA-approved dosing, RECONNECT trial data, and what off-label dose reduction means in practice for premenopausal women with HSDD.
A clinician-level review of how bremelanotide (Vyleesi) affects sleep architecture, including melanocortin receptor pharmacology, clinical trial data from RECONNECT, and practical dosing guidance for women with HSDD.
A detailed look at whether amlodipine causes weight gain, what the clinical data show, how edema gets mistaken for fat gain, and what to do if your weight changes on this medication.
A clinical breakdown of every major drug, supplement, and intervention in Bryan Johnson's Blueprint longevity protocol, with primary-source citations rating the strength of evidence behind each.
A clinical breakdown of Bryan Johnson's public statements on longevity medication, his Blueprint protocol drug and supplement stack, and what the evidence actually says about each intervention.
A guide to tadalafil dosing in patients 65 and older, covering starting doses, renal and hepatic adjustments, drug interactions, falls risk, and when to reconsider treatment.
A clinician-level guide to tadalafil pharmacogenomics, covering CYP3A4/3A5 polymorphisms, PDE5A variants, nitric-oxide pathway genetics, and how genetic testing can guide dosing of Cialis for erectile dysfunction and BPH.
A physician-level review of tadalafil (Cialis) and cancer risk signals, covering prostate, bladder, and melanoma data, PDE5 inhibitor pharmacology, and current FDA labeling status.
Long-term data show tadalafil may lower MACE and improve endothelial function in select patients, but nitrate use remains an absolute contraindication.
A GRADE-level review of tadalafil (Cialis) for erectile dysfunction and BPH, covering every major RCT, pooled analysis, and guideline recommendation with inline citations to primary sources.
A look at how tadalafil affects mood, depression, anxiety, and psychological well-being, with primary-literature citations and clinical dosing guidance.
Does stopping tadalafil (Cialis) cause rebound ED or BPH flares? An evidence-based breakdown of withdrawal, rebound physiology, and how to taper or discontinue safely.
A guide to how tadalafil (Cialis) affects erectile function, libido, orgasm, and partner satisfaction, with primary-literature citations and practical dosing guidance.
A deep dive into how tadalafil affects sleep architecture, nocturnal erections, sleep apnea, and overnight PDE5 inhibition. Includes clinical trial data, dosing considerations, and practical guidance.
A clinical reference on CJC-1295 modified GRF use in adults aged 65 and older, covering dosing considerations, renal and hepatic factors, fall risk, IGF-1 monitoring, and deprescribing, for editorial and qualified clinical review.
A guide to CJC-1295 safety in adults 65 and older, covering renal function, falls risk, drug interactions, IGF-1 monitoring, and when to deprescribe.
A synthesis of CJC-1295 (modified GRF) real-world evidence, mechanism, dosing, safety signals, and registry data, with PubMed-cited primary sources throughout.
A physician-level review of CJC-1295 (modified GRF) use in special populations including solid-organ transplant recipients, people living with HIV, older adults, and those with GH deficiency. Covers mechanism, pharmacokinetics, drug interactions, and clinical evidence.
A clinician-level review of CJC-1295 (modified GRF) cardiovascular effects, covering cardiac output, blood pressure, lipid remodeling, IGF-1 signaling, and long-term risk framing based on primary literature.
A rigorous GRADE-level review of CJC-1295 (modified GRF) clinical evidence, covering pharmacology, trial data from Teichman et al. 2006, and what the research does and does not support for GH secretagogue therapy.
A deep dive into how CJC-1295 (modified GRF) affects hair growth, skin thickness, collagen synthesis, and sebum production, with primary-literature citations and dosing context.
A clinical review of CJC-1295 modified GRF and its effects on renal function, covering GH/IGF-1 physiology, animal data, human pharmacokinetics, known risks, and prescribing considerations for patients with kidney disease.
A prescriber-level guide to recognizing, grading, and managing adverse events from finasteride and dutasteride, with dosing tables, monitoring schedules, and evidence-based mitigation strategies.